Trial Profile
A Phase II, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy and Safety of the Misoprostol Vaginal Priming Insert for Women Requiring Cervical Priming Prior to a Hysteroscopy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Misoprostol (Primary)
- Indications Labour induction
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 19 Nov 2014 New trial record